{"id":"NCT00030901","sponsor":"SWOG Cancer Research Network","briefTitle":"S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate","officialTitle":"L-Selenium-Based Chemoprevention Of Prostate Cancer Among Men With High Grade Prostatic Intraepithelial Neoplasia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2000-02","primaryCompletion":"2011-11","completion":"2011-11","firstPosted":"2003-01-27","resultsPosted":"2013-02-06","lastUpdate":"2013-02-06"},"enrollment":619,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Precancerous/Nonmalignant Condition","Prostate Cancer"],"interventions":[{"type":"DRUG","name":"L-selenomethionine","otherNames":["Selenium"]},{"type":"DRUG","name":"L-selenomethionine placebo","otherNames":["placebo"]}],"arms":[{"label":"L-selenomethionine","type":"ACTIVE_COMPARATOR"},{"label":"L-selenomethionine placebo","type":"PLACEBO_COMPARATOR"}],"summary":"RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. The use of selenium may be an effective way to prevent prostate cancer in patients who have neoplasia of the prostate.\n\nPURPOSE: Randomized phase III trial to study the effectiveness of selenium in preventing prostate cancer in patients who have neoplasia of the prostate.","primaryOutcome":{"measure":"Presence of Carcinoma of the Prostate as Measured by Biopsy","timeFrame":"3 years","effectByArm":[{"arm":"Selenium","deltaMin":48,"sd":null},{"arm":"Placebo","deltaMin":49,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.73"}]},"eligibility":{"minAge":"40 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["16896036"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":203},"commonTop":["Fatigue/malaise/lethargy","Urinary frequency/urgency","Nail changes","GI-other","Rash/desquamation"]}}